Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (161-170 of 596) with videos related to

Pageof 60
Sort By:
Genes, Chromosomes & Cancer|November 11, 2011
Gene expression of BAALC, CDKN1B, ERG, and MN1 adds independent prognostic information to cytogenetics and molecular mutations in adult acute myeloid leukemiaClaudia Haferlach, Wolfgang Kern, Sonja Schindela, et al.
Cytometry. Part B, Clinical Cytometry|December 7, 2011
Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemiaWolfgang Kern, Ulrike Bacher, Claudia Haferlach, et al.
Experimental Hematology|October 5, 2010
A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controlsSusanne Schnittger, Ulrike Bacher, Christiane Eder, et al.
British Journal of Haematology|July 24, 2009
RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemiaSusanne Schnittger, Ulrike Bacher, Wolfgang Kern, et al.
BMC Cancer|August 3, 2021
Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemiaWencke Walter, Rabia Shahswar, Anna Stengel, et al.
Blood Advances|February 3, 2023
Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDSAnna Stengel, Torsten Haferlach, Constance Baer, et al.
Cancer Genetics and Cytogenetics|July 18, 2006
Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22)Ulrike Bacher, Susanne Schnittger, Wolfgang Kern, et al.
Blood|May 10, 2005
Global approach to the diagnosis of leukemia using gene expression profilingTorsten Haferlach, Alexander Kohlmann, Susanne Schnittger, et al.
Blood Advances|July 9, 2024
Characterization of cases with the rare cytogenetic abnormality i(7)(p10) reveals an association with IDH2-mutated AMLAnna Stengel, Katharina Hörst, Constanze Kühn, et al.
Haematologica|December 7, 2005
Detailed analysis of FLT3 expression levels in acute myeloid leukemiaFlorian Kuchenbauer, Wolfgang Kern, Claudia Schoch, et al.
Pageof 60

Showing results (161-170 of 596) with videos related to

Sort By:
Pageof 60
Genes, Chromosomes & Cancer|November 11, 2011
Gene expression of BAALC, CDKN1B, ERG, and MN1 adds independent prognostic information to cytogenetics and molecular mutations in adult acute myeloid leukemiaClaudia Haferlach, Wolfgang Kern, Sonja Schindela, et al.
Cytometry. Part B, Clinical Cytometry|December 7, 2011
Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemiaWolfgang Kern, Ulrike Bacher, Claudia Haferlach, et al.
Experimental Hematology|October 5, 2010
A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controlsSusanne Schnittger, Ulrike Bacher, Christiane Eder, et al.
British Journal of Haematology|July 24, 2009
RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemiaSusanne Schnittger, Ulrike Bacher, Wolfgang Kern, et al.
BMC Cancer|August 3, 2021
Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemiaWencke Walter, Rabia Shahswar, Anna Stengel, et al.
Blood Advances|February 3, 2023
Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDSAnna Stengel, Torsten Haferlach, Constance Baer, et al.
Cancer Genetics and Cytogenetics|July 18, 2006
Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22)Ulrike Bacher, Susanne Schnittger, Wolfgang Kern, et al.
Blood|May 10, 2005
Global approach to the diagnosis of leukemia using gene expression profilingTorsten Haferlach, Alexander Kohlmann, Susanne Schnittger, et al.
Blood Advances|July 9, 2024
Characterization of cases with the rare cytogenetic abnormality i(7)(p10) reveals an association with IDH2-mutated AMLAnna Stengel, Katharina Hörst, Constanze Kühn, et al.
Haematologica|December 7, 2005
Detailed analysis of FLT3 expression levels in acute myeloid leukemiaFlorian Kuchenbauer, Wolfgang Kern, Claudia Schoch, et al.
Pageof 60